(a)
name, address and telephone number of the main contact for information on the product, clinical trial and emergency unblinding; this may be the sponsor, contract research organisation or investigator (for the purpose of this Annex this is referred to as the ’main contact’);
← anx_VI__cpt_1__cpt_1__point_1__text_1 · All articles · anx_VI__cpt_1__cpt_1__point_1__point_a__text_1 →
Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.